$AEMD "We are truly grateful that our colleagues at the Boston University CTE Center have expanded our opportunity to validate our Tausome™ biomarker as a candidate to detect and monitor CTE in living individuals," stated Jim Joyce, Executive Chairman at Exosome Sciences and Chairman and CEO of Aethlon Medical. #CTE #collaboration #Aethlon Medical

http://finance.yahoo.com/news/aethlon-medical...00370.html